Investigation of the HLA class II Antigen Presentation Pathway in Estrogen Receptor Negative and Estrogen Receptor Positive Breast Carcinoma.

雌激素受体阴性和雌激素受体阳性乳腺癌中 HLA II 类抗原呈递途径的研究。

• 批准号: 186899
• 负责人: Mostafa Ahmed
• 金额: $ 3.28万
• 依托单位: Memorial University of Newfoundland
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2009
• 资助国家: 加拿大
• 起止时间: 2009-02-01 至 2011-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=186899&lang=en
• 关键词: Anti-Estrogen Receptors; Antigen Processing And Presentation; Breast Cancer; Cd4+T-Cells; Ciita; Estrogen Receptor And Estradiol; Hla Class Ii Regulation; Hlas Class Ii Chaperones; Molecular Immunology; Tumor Immunity

Breast cancer is the most common cancer affecting Canadian women and accounts for nearly 30% of all newly diagnosed cancer cases. Despite a large number of new treatment choices including immune-based therapies, it is still difficult to predict the outco

乳腺癌是加拿大女性最常见的癌症，占所有新诊断癌症病例的近 30%。 尽管有大量新的治疗选择，包括基于免疫的疗法，但仍然很难预测结果